Pub Date : 2024-10-07eCollection Date: 2024-01-01DOI: 10.62675/2965-2774.20240213-en
Luis Felipe da Fonseca Reis, João Paulo Arruda de Oliveira, Arthur de Sá Ferreira, Agnaldo José Lopes
{"title":"Reply to: Factors associated with mortality in mechanically ventilated patients with severe acute respiratory syndrome due to COVID-19 evolution.","authors":"Luis Felipe da Fonseca Reis, João Paulo Arruda de Oliveira, Arthur de Sá Ferreira, Agnaldo José Lopes","doi":"10.62675/2965-2774.20240213-en","DOIUrl":"10.62675/2965-2774.20240213-en","url":null,"abstract":"","PeriodicalId":72721,"journal":{"name":"Critical care science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463990/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-10-07eCollection Date: 2024-01-01DOI: 10.62675/2965-2774.20240043-en
Cláudia Severgnini Eugênio, Thiago Wendt Viola, Francisco Sindermann Lumertz, Adriana Valéria Hoffmeister Daltrozo, Maria Eduarda Ramos Saraiva, Júlia Borges Casagrande, Rafael Fernandes Zanin, Márcio Manozzo Boniatti
Objective: The aim of this study was to investigate whether there is an association between hair cortisol concentrations and acute stress symptoms in family members of critically ill patients.
Methods: A cross-sectional study was conducted in an adult intensive care unit of a tertiary hospital in Porto Alegre, Brazil, from August 2021 to February 2022. Family members of intensive care unit patients admitted for more than 10 days were approached for enrollment. We collected sociodemographic data and assessed resilience, religiosity, and symptoms of acute stress among family members. Samples of family members' hair were collected shortly after the interview to measure the hair cortisol concentration.
Results: A total of 110 family members were included in this study. Eighty-eight (80.0%) family members presented with symptoms of acute stress. The median hair cortisol concentration was 2.37pg/mg (1.16 - 5.06pg/mg). There was no significant difference in hair cortisol concentration between family members with and without acute stress symptoms (p = 0.419). According to the multivariate analysis, only the fact that the patient was alert at the time of the family member's interview was significantly associated with the prevalence of acute stress symptoms in the family member.
Conclusion: We did not find an association between the hair cortisol concentration of family members in hair segments in the months prior to admission to the intensive care unit and the occurrence of acute stress symptoms.
{"title":"Association between hair cortisol concentration and acute stress symptoms in family members of critically ill patients: a cross-sectional study.","authors":"Cláudia Severgnini Eugênio, Thiago Wendt Viola, Francisco Sindermann Lumertz, Adriana Valéria Hoffmeister Daltrozo, Maria Eduarda Ramos Saraiva, Júlia Borges Casagrande, Rafael Fernandes Zanin, Márcio Manozzo Boniatti","doi":"10.62675/2965-2774.20240043-en","DOIUrl":"10.62675/2965-2774.20240043-en","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to investigate whether there is an association between hair cortisol concentrations and acute stress symptoms in family members of critically ill patients.</p><p><strong>Methods: </strong>A cross-sectional study was conducted in an adult intensive care unit of a tertiary hospital in Porto Alegre, Brazil, from August 2021 to February 2022. Family members of intensive care unit patients admitted for more than 10 days were approached for enrollment. We collected sociodemographic data and assessed resilience, religiosity, and symptoms of acute stress among family members. Samples of family members' hair were collected shortly after the interview to measure the hair cortisol concentration.</p><p><strong>Results: </strong>A total of 110 family members were included in this study. Eighty-eight (80.0%) family members presented with symptoms of acute stress. The median hair cortisol concentration was 2.37pg/mg (1.16 - 5.06pg/mg). There was no significant difference in hair cortisol concentration between family members with and without acute stress symptoms (p = 0.419). According to the multivariate analysis, only the fact that the patient was alert at the time of the family member's interview was significantly associated with the prevalence of acute stress symptoms in the family member.</p><p><strong>Conclusion: </strong>We did not find an association between the hair cortisol concentration of family members in hair segments in the months prior to admission to the intensive care unit and the occurrence of acute stress symptoms.</p>","PeriodicalId":72721,"journal":{"name":"Critical care science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463979/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142395711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-27eCollection Date: 2024-01-01DOI: 10.62675/2965-2774.20240236-en
José Pedro Cidade, Vicente Cês Souza-Dantas, Rafaela Braga Mamfrim, Renata Carnevale Miranda, Henrique Tommasi Caroli, Natália Almeida Oliveira, Alessandra Figueiredo Thompson, Gabriela E Oliveira, Pedro Póvoa
Objective: To elucidate the impact of lymphopenia on critical COVID-19 patient outcomes.
Methods: We conducted a multicenter prospective cohort study across five hospitals in Portugal and Brazil from 2020 to 2021. The study included adult patients admitted to the intensive care unit with SARS-CoV-2 pneumonia. Patients were categorized into two groups based on their lymphocyte counts within 48 hours of intensive care unit admission: the Lymphopenia Group (lymphocyte serum count < 1 × 109/L) and the Nonlymphopenia Group. Multivariate logistic regression, propensity score matching, Kaplan‒Meier survival curve analysis and Cox proportional hazards regression analysis were used.
Results: A total of 912 patients were enrolled, with 191 (20.9%) in the Nonlymphopenia Group and 721 (79.1%) in the Lymphopenia Group. Lymphopenia patients displayed significantly elevated disease severity indices, including Sequential Organ Failure Assessment and Simplified Acute Physiology Score 3 scores, at intensive care unit admission (p = 0.001 and p < 0.001, respectively). Additionally, they presented heightened requirements for vasopressor support (p = 0.045) and prolonged intensive care unit and in-hospital stays (both p < 0.001). Multivariate logistic regression analysis after propensity score matching revealed a significant contribution of lymphopenia to mortality, with an odds ratio of 1,621 (95%CI: 1,275 - 2,048; p < 0.001). Interaction models revealed an increase of 8% in mortality for each decade of longevity in patients with concomitant lymphopenia. In the subanalysis utilizing three-group stratification, the Severe Lymphopenia Group had the highest mortality rate, not only in direct comparisons but also in Kaplan‒Meier survival analysis (log-rank test p = 0.0048).
Conclusion: Lymphopenia in COVID-19 patients is associated with increased disease severity and an increased risk of mortality, underscoring the need for prompt support for critically ill high-risk patients. These findings offer important insights into improving patient care strategies for COVID-19 patients.
目的:阐明淋巴细胞减少症对危重 COVID-19 患者预后的影响:阐明淋巴细胞减少症对COVID-19危重患者预后的影响:我们于 2020 年至 2021 年在葡萄牙和巴西的五家医院开展了一项多中心前瞻性队列研究。研究对象包括因 SARS-CoV-2 肺炎入住重症监护病房的成年患者。根据患者入院 48 小时内的淋巴细胞计数将其分为两组:淋巴细胞减少组(淋巴细胞血清计数小于 1 × 109/L)和非淋巴细胞减少组。研究采用了多变量逻辑回归、倾向得分匹配、卡普兰-梅耶生存曲线分析和考克斯比例危险回归分析:共有 912 名患者入组,其中非淋巴细胞减少症组有 191 人(20.9%),淋巴细胞减少症组有 721 人(79.1%)。淋巴细胞减少症患者在进入重症监护室时,疾病严重程度指数(包括序贯器官衰竭评估和简化急性生理学评分 3)明显升高(分别为 p = 0.001 和 p < 0.001)。此外,他们需要更多的血管加压支持(p = 0.045),重症监护室和住院时间延长(均 p < 0.001)。倾向评分匹配后的多变量逻辑回归分析显示,淋巴细胞减少症对死亡率有显著影响,几率比为 1,621 (95%CI: 1,275 - 2,048; p < 0.001)。交互模型显示,伴有淋巴细胞减少症的患者每长寿十年,死亡率就会增加 8%。在采用三组分层的子分析中,严重淋巴细胞减少症组的死亡率最高,不仅在直接比较中如此,在卡普兰-梅耶生存分析中也是如此(对数秩检验 p = 0.0048):结论:COVID-19 患者的淋巴细胞减少症与疾病严重程度的增加和死亡风险的增加有关,强调了对重症高危患者提供及时支持的必要性。这些发现为改善 COVID-19 患者的护理策略提供了重要启示。
{"title":"Advancing insights in critical COVID-19: unraveling lymphopenia through propensity score matching - Findings from the Multicenter LYMPH-COVID Study.","authors":"José Pedro Cidade, Vicente Cês Souza-Dantas, Rafaela Braga Mamfrim, Renata Carnevale Miranda, Henrique Tommasi Caroli, Natália Almeida Oliveira, Alessandra Figueiredo Thompson, Gabriela E Oliveira, Pedro Póvoa","doi":"10.62675/2965-2774.20240236-en","DOIUrl":"10.62675/2965-2774.20240236-en","url":null,"abstract":"<p><strong>Objective: </strong>To elucidate the impact of lymphopenia on critical COVID-19 patient outcomes.</p><p><strong>Methods: </strong>We conducted a multicenter prospective cohort study across five hospitals in Portugal and Brazil from 2020 to 2021. The study included adult patients admitted to the intensive care unit with SARS-CoV-2 pneumonia. Patients were categorized into two groups based on their lymphocyte counts within 48 hours of intensive care unit admission: the Lymphopenia Group (lymphocyte serum count < 1 × 109/L) and the Nonlymphopenia Group. Multivariate logistic regression, propensity score matching, Kaplan‒Meier survival curve analysis and Cox proportional hazards regression analysis were used.</p><p><strong>Results: </strong>A total of 912 patients were enrolled, with 191 (20.9%) in the Nonlymphopenia Group and 721 (79.1%) in the Lymphopenia Group. Lymphopenia patients displayed significantly elevated disease severity indices, including Sequential Organ Failure Assessment and Simplified Acute Physiology Score 3 scores, at intensive care unit admission (p = 0.001 and p < 0.001, respectively). Additionally, they presented heightened requirements for vasopressor support (p = 0.045) and prolonged intensive care unit and in-hospital stays (both p < 0.001). Multivariate logistic regression analysis after propensity score matching revealed a significant contribution of lymphopenia to mortality, with an odds ratio of 1,621 (95%CI: 1,275 - 2,048; p < 0.001). Interaction models revealed an increase of 8% in mortality for each decade of longevity in patients with concomitant lymphopenia. In the subanalysis utilizing three-group stratification, the Severe Lymphopenia Group had the highest mortality rate, not only in direct comparisons but also in Kaplan‒Meier survival analysis (log-rank test p = 0.0048).</p><p><strong>Conclusion: </strong>Lymphopenia in COVID-19 patients is associated with increased disease severity and an increased risk of mortality, underscoring the need for prompt support for critically ill high-risk patients. These findings offer important insights into improving patient care strategies for COVID-19 patients.</p>","PeriodicalId":72721,"journal":{"name":"Critical care science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463993/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-27eCollection Date: 2024-01-01DOI: 10.62675/2965-2774.20240053-en
Bruno Martins Tomazini, Thabata Silva Veiga, Renato Hideo Nakagawa Santos, Viviane Bezerra Campos, Samira Martins Tokunaga, Elton Sousa Santos, Leticia Galvão Barbante, Renato da Costa Maia, Karina Leal Negrelli, Nanci Valeis, Eliana Vieira Santucci, Ligia Nasi Laranjeira, Fernando Azevedo Medrado, Thiago Costa Lisboa, Bruno Adler Maccagnan Pinheiro Besen, Antônio Paulo Nassar Junior, Viviane Cordeiro Veiga, Adriano José Pereira, Alexandre Biasi Cavalcanti
Background: Critically ill patients are at increased risk of health care-associated infections due to various devices (central line-associated bloodstream infection, catheter-associated urinary tract infection, and ventilator-associated pneumonia), which pose a significant threat to this population. Among several strategies, daily bathing with chlorhexidine digluconate, a water-soluble antiseptic, has been studied as an intervention to decrease the incidence of health care-associated infections in the intensive care unit; however, its ability to reduce all health care-associated infections due to various devices is unclear. We designed the Daily Chlorhexidine Bath for Health Care Associated Infection Prevention (CLEAN-IT) trial to assess whether daily chlorhexidine digluconate bathing reduces the incidence of health care-associated infections in critically ill patients compared with soap and water bathing.
Methods: The CLEAN-IT trial is a multicenter, open-label, cluster randomized crossover clinical trial. All adult patients admitted to the participating intensive care units will be included in the trial. Each cluster (intensive care unit) will be randomized to perform either initial chlorhexidine digluconate bathing or soap and water bathing with crossover for a period of 3 to 6 months, depending on the time of each center's entrance to the study, with a 1-month washout period between chlorhexidine digluconate bathing and soap and water bathing transitions. The primary outcome is the incidence of health care-associated infections due to devices. The secondary outcomes are the incidence of each specific health care-associated infection, rates of microbiological cultures positive for multidrug-resistant pathogens, antibiotic use, intensive care unit and hospital length of stay, and intensive care unit and hospital mortality.
Conclusion: The CLEAN-IT trial will be used to study feasible and affordable interventions that might reduce the health care-associated infection burden in critically ill patients.
{"title":"Daily Chlorhexidine Bath for Health Care Associated Infection Prevention (CLEAN-IT): protocol for a multicenter cluster randomized crossover open-label trial.","authors":"Bruno Martins Tomazini, Thabata Silva Veiga, Renato Hideo Nakagawa Santos, Viviane Bezerra Campos, Samira Martins Tokunaga, Elton Sousa Santos, Leticia Galvão Barbante, Renato da Costa Maia, Karina Leal Negrelli, Nanci Valeis, Eliana Vieira Santucci, Ligia Nasi Laranjeira, Fernando Azevedo Medrado, Thiago Costa Lisboa, Bruno Adler Maccagnan Pinheiro Besen, Antônio Paulo Nassar Junior, Viviane Cordeiro Veiga, Adriano José Pereira, Alexandre Biasi Cavalcanti","doi":"10.62675/2965-2774.20240053-en","DOIUrl":"10.62675/2965-2774.20240053-en","url":null,"abstract":"<p><strong>Background: </strong>Critically ill patients are at increased risk of health care-associated infections due to various devices (central line-associated bloodstream infection, catheter-associated urinary tract infection, and ventilator-associated pneumonia), which pose a significant threat to this population. Among several strategies, daily bathing with chlorhexidine digluconate, a water-soluble antiseptic, has been studied as an intervention to decrease the incidence of health care-associated infections in the intensive care unit; however, its ability to reduce all health care-associated infections due to various devices is unclear. We designed the Daily Chlorhexidine Bath for Health Care Associated Infection Prevention (CLEAN-IT) trial to assess whether daily chlorhexidine digluconate bathing reduces the incidence of health care-associated infections in critically ill patients compared with soap and water bathing.</p><p><strong>Methods: </strong>The CLEAN-IT trial is a multicenter, open-label, cluster randomized crossover clinical trial. All adult patients admitted to the participating intensive care units will be included in the trial. Each cluster (intensive care unit) will be randomized to perform either initial chlorhexidine digluconate bathing or soap and water bathing with crossover for a period of 3 to 6 months, depending on the time of each center's entrance to the study, with a 1-month washout period between chlorhexidine digluconate bathing and soap and water bathing transitions. The primary outcome is the incidence of health care-associated infections due to devices. The secondary outcomes are the incidence of each specific health care-associated infection, rates of microbiological cultures positive for multidrug-resistant pathogens, antibiotic use, intensive care unit and hospital length of stay, and intensive care unit and hospital mortality.</p><p><strong>Conclusion: </strong>The CLEAN-IT trial will be used to study feasible and affordable interventions that might reduce the health care-associated infection burden in critically ill patients.</p>","PeriodicalId":72721,"journal":{"name":"Critical care science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463980/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-27eCollection Date: 2024-01-01DOI: 10.62675/2965-2774.20240187-en
Elisabete Monteiro, Sofia Rocha E Silva, Marek Czosnyka, José Artur Paiva, Celeste Dias
{"title":"Reply to: Neurocritical care management supported by multimodal brain monitoring after acute brain injury.","authors":"Elisabete Monteiro, Sofia Rocha E Silva, Marek Czosnyka, José Artur Paiva, Celeste Dias","doi":"10.62675/2965-2774.20240187-en","DOIUrl":"10.62675/2965-2774.20240187-en","url":null,"abstract":"","PeriodicalId":72721,"journal":{"name":"Critical care science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142367682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: To address the current practice of liberating patients from invasive mechanical ventilation in pediatric intensive care units, with a focus on the use of standardized protocols, criteria, parameters, and indications for noninvasive respiratory support postextubation.
Methods: Electronic research was carried out from November 2021 to May 2022 in Ibero-American pediatric intensive care units. Physicians and respiratory therapists participated, with a single representative for each pediatric intensive care unit included. There were no interventions.
Results: The response rate was 48.9% (138/282), representing 10 Ibero-American countries. Written invasive mechanical ventilation liberation protocols were available in only 34.1% (47/138) of the pediatric intensive care units, and their use was associated with the presence of respiratory therapists (OR 3.85; 95%CI 1.79 - 8.33; p = 0.0008). The most common method of liberation involved a gradual reduction in ventilatory support plus a spontaneous breathing trial (47.1%). The mean spontaneous breathing trial duration was 60 - 120 minutes in 64.8% of the responses. The presence of a respiratory therapist in the pediatric intensive care unit was the only variable associated with the use of a spontaneous breathing trial as the primary method of liberation from invasive mechanical ventilation (OR 5.1; 95%CI 2.1 - 12.5). Noninvasive respiratory support protocols were not frequently used postextubation (40.4%). Nearly half of the respondents (43.5%) reported a preference for using bilevel positive airway pressure as the mode of noninvasive ventilation postextubation.
Conclusion: A high proportion of Ibero-American pediatric intensive care units lack liberation protocols. Our study highlights substantial variability in extubation readiness practices, underscoring the need for standardization in this process. However, the presence of a respiratory therapist was associated with increased adherence to guidelines.
{"title":"Clinical practices related to liberation from mechanical ventilation in Latin American pediatric intensive care units: survey of the Sociedad Latino-Americana de Cuidados Intensivos Pediátricos Mechanical Ventilation Liberation Group.","authors":"Alejandra Retta, Analía Fernández, Ezequiel Monteverde, Cintia Johnston, Andrés Castillo-Moya, Silvio Torres, Jesus Dominguez-Rojas, Matias G Herrera, Vlademir Aguilera-Avendaño, Yúrika López-Alarcón, Davi Pascual Rojas Flores, Manuel Eduardo Munaico-Abanto, Júlia Acuña, Rosa León, Carla Ferreira, Gabriela Sequeira, Cristina Camilo, Mauricio Yunge, Yolanda López Fernández","doi":"10.62675/2965-2774.20240066-en","DOIUrl":"10.62675/2965-2774.20240066-en","url":null,"abstract":"<p><strong>Objective: </strong>To address the current practice of liberating patients from invasive mechanical ventilation in pediatric intensive care units, with a focus on the use of standardized protocols, criteria, parameters, and indications for noninvasive respiratory support postextubation.</p><p><strong>Methods: </strong>Electronic research was carried out from November 2021 to May 2022 in Ibero-American pediatric intensive care units. Physicians and respiratory therapists participated, with a single representative for each pediatric intensive care unit included. There were no interventions.</p><p><strong>Results: </strong>The response rate was 48.9% (138/282), representing 10 Ibero-American countries. Written invasive mechanical ventilation liberation protocols were available in only 34.1% (47/138) of the pediatric intensive care units, and their use was associated with the presence of respiratory therapists (OR 3.85; 95%CI 1.79 - 8.33; p = 0.0008). The most common method of liberation involved a gradual reduction in ventilatory support plus a spontaneous breathing trial (47.1%). The mean spontaneous breathing trial duration was 60 - 120 minutes in 64.8% of the responses. The presence of a respiratory therapist in the pediatric intensive care unit was the only variable associated with the use of a spontaneous breathing trial as the primary method of liberation from invasive mechanical ventilation (OR 5.1; 95%CI 2.1 - 12.5). Noninvasive respiratory support protocols were not frequently used postextubation (40.4%). Nearly half of the respondents (43.5%) reported a preference for using bilevel positive airway pressure as the mode of noninvasive ventilation postextubation.</p><p><strong>Conclusion: </strong>A high proportion of Ibero-American pediatric intensive care units lack liberation protocols. Our study highlights substantial variability in extubation readiness practices, underscoring the need for standardization in this process. However, the presence of a respiratory therapist was associated with increased adherence to guidelines.</p>","PeriodicalId":72721,"journal":{"name":"Critical care science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463992/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142333678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-09eCollection Date: 2024-01-01DOI: 10.62675/2965-2774.20240021-en
Edison Iglesias de Oliveira Vidal, Sabrina Correa da Costa Ribeiro, Maria Júlia Kovacs, Luciano Máximo da Silva, Daniele Pompei Sacardo, Simone Brasil de Oliveira Iglesias, Josimário João da Silva, Cinara Carneiro Neves, Diego Lima Ribeiro, Fernanda Gomes Lopes
The issue of withrawing and withholding life-sustaining interventions is an important source of controversy among healthcare professionals caring for patients with serious illnesses. Misguided decisions, both in terms of the introduction/maintenance and the withdrawal/withholding of these measures, represent a source of avoidable suffering for patients, their loved ones, and healthcare professionals. This document represents the position statement of the Bioethics Committee of the Brazilian Palliative Care Academy on this issue and establishes seven principles to guide, from a bioethical perspective, the approach to situations related to this topic in the context of palliative care in Brazil. The position statement establishes the equivalence between the withdrawal and withholding of life-sustaining interventions and the inadequacy related to initiating or maintaining such measures in contexts where they are in disagreement with the values and care goals defined together with patients and their families. Additionally, the position statement distinguishes strictly futile treatments from potentially inappropriate treatments and elucidates their critical implications for the appropriateness of the medical decision-making process in this context. Finally, we address the issue of conscientious objection and its limits, determine that the ethical commitment to the relief of suffering should not be influenced by the decision to employ or not employ life-sustaining interventions and warn against the use of language that causes patients/families to believe that only one of the available options related to the use or nonuse of these interventions will enable the relief of suffering.
{"title":"Position statement of the Brazilian Palliative Care Academy on withdrawing and withholding life-sustaining interventions in the context of palliative care.","authors":"Edison Iglesias de Oliveira Vidal, Sabrina Correa da Costa Ribeiro, Maria Júlia Kovacs, Luciano Máximo da Silva, Daniele Pompei Sacardo, Simone Brasil de Oliveira Iglesias, Josimário João da Silva, Cinara Carneiro Neves, Diego Lima Ribeiro, Fernanda Gomes Lopes","doi":"10.62675/2965-2774.20240021-en","DOIUrl":"10.62675/2965-2774.20240021-en","url":null,"abstract":"<p><p>The issue of withrawing and withholding life-sustaining interventions is an important source of controversy among healthcare professionals caring for patients with serious illnesses. Misguided decisions, both in terms of the introduction/maintenance and the withdrawal/withholding of these measures, represent a source of avoidable suffering for patients, their loved ones, and healthcare professionals. This document represents the position statement of the Bioethics Committee of the Brazilian Palliative Care Academy on this issue and establishes seven principles to guide, from a bioethical perspective, the approach to situations related to this topic in the context of palliative care in Brazil. The position statement establishes the equivalence between the withdrawal and withholding of life-sustaining interventions and the inadequacy related to initiating or maintaining such measures in contexts where they are in disagreement with the values and care goals defined together with patients and their families. Additionally, the position statement distinguishes strictly futile treatments from potentially inappropriate treatments and elucidates their critical implications for the appropriateness of the medical decision-making process in this context. Finally, we address the issue of conscientious objection and its limits, determine that the ethical commitment to the relief of suffering should not be influenced by the decision to employ or not employ life-sustaining interventions and warn against the use of language that causes patients/families to believe that only one of the available options related to the use or nonuse of these interventions will enable the relief of suffering.</p>","PeriodicalId":72721,"journal":{"name":"Critical care science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-09eCollection Date: 2024-01-01DOI: 10.62675/2965-2774.20240196Ed-en
Regis Goulart Rosa, Livia Biason, Lara Patricia Kretzer
{"title":"The suspension and nonimplementation of life support interventions in palliative care.","authors":"Regis Goulart Rosa, Livia Biason, Lara Patricia Kretzer","doi":"10.62675/2965-2774.20240196Ed-en","DOIUrl":"10.62675/2965-2774.20240196Ed-en","url":null,"abstract":"","PeriodicalId":72721,"journal":{"name":"Critical care science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-09-02eCollection Date: 2024-01-01DOI: 10.62675/2965-2774.20240150-en
Marcio Soares, Lunna Perdigão Borges, Leonardo Dos Santos Lourenco Bastos, Fernando Godinho Zampieri, Gabriel Alves Miranda, Pedro Kurtz, Suzana Margareth Lobo, Lucas Rodrigo Garcia de Mello, Gastón Burghi, Ederlon Rezende, Otávio Tavares Ranzani, Jorge Ibrain Figueira Salluh
In recent decades, several databases of critically ill patients have become available in both low-, middle-, and high-income countries from all continents. These databases are also rich sources of data for the surveillance of emerging diseases, intensive care unit performance evaluation and benchmarking, quality improvement projects and clinical research. The Epimed Monitor database is turning 15 years old in 2024 and has become one of the largest of these databases. In recent years, there has been rapid geographical expansion, an increase in the number of participating intensive care units and hospitals, and the addition of several new variables and scores, allowing a more complete characterization of patients to facilitate multicenter clinical studies. As of December 2023, the database was being used regularly for 23,852 beds in 1,723 intensive care units and 763 hospitals from ten countries, totaling more than 5.6 million admissions. In addition, critical care societies have adopted the system and its database to establish national registries and international collaborations. In the present review, we provide an updated description of the database; report experiences of its use in critical care for quality improvement initiatives, national registries and clinical research; and explore other potential future perspectives and developments.
{"title":"Update on the Epimed Monitor Adult ICU Database: 15 years of its use in national registries, quality improvement initiatives and clinical research.","authors":"Marcio Soares, Lunna Perdigão Borges, Leonardo Dos Santos Lourenco Bastos, Fernando Godinho Zampieri, Gabriel Alves Miranda, Pedro Kurtz, Suzana Margareth Lobo, Lucas Rodrigo Garcia de Mello, Gastón Burghi, Ederlon Rezende, Otávio Tavares Ranzani, Jorge Ibrain Figueira Salluh","doi":"10.62675/2965-2774.20240150-en","DOIUrl":"10.62675/2965-2774.20240150-en","url":null,"abstract":"<p><p>In recent decades, several databases of critically ill patients have become available in both low-, middle-, and high-income countries from all continents. These databases are also rich sources of data for the surveillance of emerging diseases, intensive care unit performance evaluation and benchmarking, quality improvement projects and clinical research. The Epimed Monitor database is turning 15 years old in 2024 and has become one of the largest of these databases. In recent years, there has been rapid geographical expansion, an increase in the number of participating intensive care units and hospitals, and the addition of several new variables and scores, allowing a more complete characterization of patients to facilitate multicenter clinical studies. As of December 2023, the database was being used regularly for 23,852 beds in 1,723 intensive care units and 763 hospitals from ten countries, totaling more than 5.6 million admissions. In addition, critical care societies have adopted the system and its database to establish national registries and international collaborations. In the present review, we provide an updated description of the database; report experiences of its use in critical care for quality improvement initiatives, national registries and clinical research; and explore other potential future perspectives and developments.</p>","PeriodicalId":72721,"journal":{"name":"Critical care science","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11463981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142127550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}